Pfizer Sues Chinese Agency Over Rejected Envacar Trademark

Law360, New York (November 26, 2004, 12:00 AM EST) -- Pfizer Inc. has sued China's State Administration for Industry and Commerce, alleging that the agency unfairly rejected its application for domestic trademark protection for blood-pressure drug Envacar.

In an opening session at the First Intermediate Court of Beijing, the U.S. drug maker maintained it twice submitted an application to the agency to register Envacar as a trademark for the drug, the Beijing Times reported.

Pfizer made its first application in September 2001, but the application was rejected on the grounds that a dictionary published by state-owned...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.